Procept Biorobotics: Grows by 83% in Q1 and Raises Sales Forecast. The AQUABEAM System Could be Considered for Prostate Cancer Treatment!
Robotics stocks are one of the most important investment trends. Procept Biorobotics broke out to a 52-week high and is a leader stock. The 83% growth in the 1st quarter was convincing. The forecast was raised. An expansion into prostate cancer treatment is generating great imagination. Robotics is one of the most exciting investment trends. Procept Biorobotics (PRCT) currently stands out in this regard. After yesterday's figures and the updated outlook, the share moved to a 52-week high. With its AQUABEAM robotic system, the group...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
Already registered? Log In
At an event, Tesla CEO Elon Musk explained his thoughts on the future of the electric car manufacturer and the influence of AI. Investors and Teslafans...
At Adobe MAX, the world's largest creative trade show, held from October 10 to October 12, the leading image-editing software provider unveiled new models...
array (
'ID' => '3685',
'post_author' =>
array (
'ID' => '3',
'user_url' => '',
'display_name' => 'Chiara Ferrario',
'user_registered' => '2023-09-12 13:13:33',
'nickname' => 'ChiaraFerrario',
'first_name' => 'Chiara',
'last_name' => 'Ferrario',
'description' => '',
'description_en' => '',
'description_es' => '',
'description_fr' => '',
'description_it' => '',
'freelancer' => '0',
'passive' => '0',
'twitter_link' => '',
'profile_image' => '',
'name' => 'Chiara Ferrario',
'name_short' => 'C. Ferrario',
'slug' => 'chiara-ferrario',
),
'post_date' => '2024-05-03 12:42:38',
'post_date_gmt' => '2024-05-03 10:42:38',
'post_content' => '
- Robotics stocks are one of the most important investment trends. Procept Biorobotics broke out to a 52-week high and is a leader stock.
- The 83% growth in the 1st quarter was convincing. The forecast was raised. An expansion into prostate cancer treatment is generating great imagination.
Robotics is one of the most exciting investment trends. Procept Biorobotics (PRCT) currently stands out in this regard. After yesterday\'s figures and the updated outlook, the share moved to a 52-week high.
With its AQUABEAM robotic system, the group enables aquablation therapy, in which prostate tissue is removed using water pressure. The system from Procept BioRobotics is used in the treatment of prostate hyperplasia, a benign enlargement of the prostate that makes urination difficult. This new, gentle method is beginning to catch on.
As reported on May 1, 2024, the company achieved 83% growth to $44.5 million in the first quarter. Consumables accounted for $23.6 million and saw a 101% increase in revenue. In the long term, when the installed base of currently 354 robots has increased significantly, the recurring, high-margin revenue will be generated by consumables. This is because the market addressed is 2,700 hospitals in size. New customers from the hospital sector in particular opted for the robotic system. At the bottom line, the group still posted a net loss of $26 million. This will change in the long term. The story is comparable to Intutitive Surgical, which already has over 8,000 systems installed with its surgical robots and is now living off the consumables business.
Because demand is strong, Procept Biorobotics has raised its 2024 outlook. Sales growth should be 57% to $213.5 million. Previously, $210 million was assumed. EBITDA will be less strongly negative with a loss of $70 million than previously with a loss of $73 million. It is also exciting that aquablation therapy could also be used in the treatment of prostate cancer to reduce surgical damage. In addition, the investment environment for hospitals looks stable to slightly improving. Hospitals are even beginning to prioritize investments in AQUABEAM robotic systems in order to ensure competitiveness and avoid losing patients to other hospitals.
',
'post_title' => 'Procept Biorobotics: Grows by 83% in Q1 and Raises Sales Forecast. The AQUABEAM System Could be Considered for Prostate Cancer Treatment!',
'post_excerpt' => '',
'post_status' => 'publish',
'comment_status' => 'open',
'ping_status' => 'open',
'post_password' => '',
'post_name' => 'procept-biorobotics-grows-by-83-in-the-1st-quarter-and-raises-sales-forecast-the-aquabeam-system-could-be-considered-for-prostate-cancer-treatment',
'to_ping' => '',
'pinged' => '',
'post_modified' => '2024-05-03 12:42:38',
'post_modified_gmt' => '2024-05-03 10:42:38',
'post_content_filtered' => '',
'post_parent' => '0',
'guid' => 'https://tradertimes.com/wordpress/?p=3685',
'menu_order' => '0',
'post_type' => 'post',
'post_mime_type' => '',
'comment_count' => '0',
'_encloseme' => '1',
'_pingme' => '1',
'magazine' =>
array (
'ID' => '3690',
'post_title' => 'The Trader Times #83 dated May 03, 2024',
'post_content' => '',
'post_date' => '2024-05-03 12:37:54',
'post_type' => 'tradertimes',
'post_mime_type' => '',
'post_parent' => '0',
),
'seo_description' => '',
'seo_image' => '',
'seo_title' => '',
'teaser' => '',
'category' =>
array (
9 =>
array (
'term_id' => '9',
'term_taxonomy_id' => '9',
'name' => 'Top Stories',
'slug' => 'top-stories',
'description' => '',
'parent' => '0',
'lang_term_taxonomy_id' => '8',
'lang_term_id' => '8',
'lang_name' => 'English',
'lang_slug' => 'en',
'translations' =>
array (
'de' => 1,
'en' => 9,
'es' => 13,
'fr' => 17,
'it' => 21,
),
'seo_title' => '',
'seo_description' => '',
'seo_image' => '',
'sub_ids' =>
array (
0 => 9,
),
'link' => '/top-stories/',
),
),
'link' => '/top-stories/procept-biorobotics-grows-by-83-in-the-1st-quarter-and-raises-sales-forecast-the-aquabeam-system-could-be-considered-for-prostate-cancer-treatment-3685.html',
'image' =>
array (
'ID' => '3689',
'post_title' => 'future robotic arms performing automated medical health care operation for future precision surgical robot and remote control hospital equipment as wide banner design with information hologram',
'post_content' => '',
'post_date' => '2024-05-03 12:17:16',
'post_type' => 'attachment',
'post_mime_type' => 'image/jpeg',
'post_parent' => '3686',
'src' => 'https://tradertimes.com/files/2024/05/AdobeStock_714180063-scaled.jpeg',
'width' => 2560,
'height' => 1074,
'sizes' =>
array (
'thumbnail' =>
array (
'file' => 'https://tradertimes.com/files/2024/05/AdobeStock_714180063-150x150.jpeg',
'width' => 150,
'height' => 150,
'mime-type' => 'image/jpeg',
'filesize' => 23255,
),
'1536x1536' =>
array (
'file' => 'https://tradertimes.com/files/2024/05/AdobeStock_714180063-1536x644.jpeg',
'width' => 1536,
'height' => 644,
'mime-type' => 'image/jpeg',
'filesize' => 172201,
),
'2048x2048' =>
array (
'file' => 'https://tradertimes.com/files/2024/05/AdobeStock_714180063-2048x859.jpeg',
'width' => 2048,
'height' => 859,
'mime-type' => 'image/jpeg',
'filesize' => 256922,
),
'teaser' =>
array (
'file' => 'https://tradertimes.com/files/2024/05/AdobeStock_714180063-632x280.jpeg',
'width' => 632,
'height' => 280,
'mime-type' => 'image/jpeg',
'filesize' => 55875,
),
'content' =>
array (
'file' => 'https://tradertimes.com/files/2024/05/AdobeStock_714180063-1296x1678.jpeg',
'width' => 1296,
'height' => 1678,
'mime-type' => 'image/jpeg',
'filesize' => 253465,
),
'fb' =>
array (
'file' => 'https://tradertimes.com/files/2024/05/AdobeStock_714180063-1200x628.jpeg',
'width' => 1200,
'height' => 628,
'mime-type' => 'image/jpeg',
'filesize' => 140559,
'cpt_last_cropping_data' =>
array (
'x' => 251,
'y' => 0,
'x2' => 2304,
'y2' => 1074,
'original_width' => 2560,
'original_height' => 1074,
),
),
),
),
'translations' =>
array (
'de' =>
array (
'post_title' => 'Procept Biorobotics: Wächst um 83% im 1. Quartal und erhöht die Umsatzprognose. Das AQUABEAM-System könnte zur Prostatakrebsbehandlung infrage kommen!',
'post_name' => '',
'ID' => '3684',
'post_type' => 'post',
'link' => '/de/top-storys/-3684.html',
),
'en' =>
array (
'post_title' => 'Procept Biorobotics: Grows by 83% in Q1 and Raises Sales Forecast. The AQUABEAM System Could be Considered for Prostate Cancer Treatment!',
'post_name' => 'procept-biorobotics-grows-by-83-in-the-1st-quarter-and-raises-sales-forecast-the-aquabeam-system-could-be-considered-for-prostate-cancer-treatment',
'ID' => '3685',
'post_type' => 'post',
'link' => '/top-stories/procept-biorobotics-grows-by-83-in-the-1st-quarter-and-raises-sales-forecast-the-aquabeam-system-could-be-considered-for-prostate-cancer-treatment-3685.html',
),
'es' =>
array (
'post_title' => 'Procept Biorobotics: crece un 83% en el 1er trimestre y eleva su previsión de ventas. ¡El sistema AQUABEAM podría considerarse para el tratamiento del cáncer de próstata!',
'post_name' => 'procept-biorobotics-crece-un-83-en-el-1er-trimestre-y-eleva-su-previsin-de-ventas-el-sistema-aquabeam-podra-considerarse-para-el-tratamiento-del-cncer-de-prstata',
'ID' => '3686',
'post_type' => 'post',
'link' => '/es/noticias-principales/procept-biorobotics-crece-un-83-en-el-1er-trimestre-y-eleva-su-previsin-de-ventas-el-sistema-aquabeam-podra-considerarse-para-el-tratamiento-del-cncer-de-prstata-3686.html',
),
),
)
